Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Pazopanib	STARTED	Pazopanib	74
Pazopanib	STARTED	Everolimus	0
Pazopanib	COMPLETED	Pazopanib	0
Pazopanib	COMPLETED	Everolimus	0
Pazopanib	NOT COMPLETED	Pazopanib	74
Pazopanib	NOT COMPLETED	Everolimus	0
Everolimus	STARTED	Pazopanib	0
Everolimus	STARTED	Everolimus	38
Everolimus	COMPLETED	Pazopanib	0
Everolimus	COMPLETED	Everolimus	0
Everolimus	NOT COMPLETED	Pazopanib	0
Everolimus	NOT COMPLETED	Everolimus	38

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01545817/flow